GBNH(Delisted)
Greenbrook TMSยทNASDAQ
--
--(--)
GBNH Profile
Greenbrook Tms Inc.
A leading provider of FDA-cleared, non-invasive therapies for Major Depressive Disorder and other mental health disorders in the United States
890 Yonge Street, 7th Floor, Toronto, Ontario, Canada M4W 3P4
--
Greenbrook TMS Inc. was incorporated in Ontario, Canada on February 9, 2018 under the OBCA. They are the leading providers of transcranial magnetic stimulation (TMS) therapy in the United States for the treatment of major depressive disorder (" MDD ") and other mental health disorders. The Company's predecessor, TMS NeuroHealth Centers, Inc., was established in 2011 to take advantage of the opportunities created by the conversion technology of TMS, an FDA-approved non-invasive therapy for the treatment of MDD. Their business model takes advantage of the opportunity to deliver a new, differentiated service channel for TMS - patient-centric, making TMS treatment easily accessible to all patients while maintaining a high level of care.
